(Q35142736)

English

Valproate

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

Valproate. (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Charles L Bowden

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Bipolar Disorders

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

189-202

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Valproate in the treatment of acute mania. A placebo-controlled study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Depression during mania. Treatment response to lithium or divalproex.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Effect size of efficacy measures comparing divalproex, lithium and placebo in acute mania

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Divalproex sodium to treat concomitant substance abuse and mood disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Strategies to Reduce Misdiagnosis of Bipolar Depression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Mood disorders in children and adolescents: psychopharmacological treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Placebo-controlled study of divalproex sodium for agitation in dementia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Efficacy and tolerability of carbamazepine for agitation and aggression in dementia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Incidence and significance of mixed affective states in a bipolar population

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Treatment of mixed mania.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Valproic acid hepatic fatalities. II. US experience since 1984.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Selenium, zinc, and copper changes with valproic acid: possible relation to drug side effects.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

A double-blind comparison of valproate and lithium in the treatment of acute mania

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

A reevaluation of risk of in utero exposure to lithium

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Gastrointestinal tolerance of divalproex sodium

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: a pharmacoepidemiology study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Mania: differential effects of previous depressive and manic episodes on response to treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Maintenance treatment in bipolar disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Valproic acid amide in the treatment of affective and schizoaffective disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

A history of substance abuse complicates remission from acute mania in bipolar disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Treatment of dementia with behavioral disturbance using divalproex or a combination of divalproex and a neuroleptic.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Mania. Diagnosis, state measurement and prediction of treatment response

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Serum valproate levels in 6 breastfeeding mother-infant pairs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Intravenous Valproate Loading in Acutely Manic and Depressed Bipolar I Patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Valproate treatment of mania

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

21 January 2018

Role of newer medications for bipolar disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Valproate as a loading treatment in acute mania

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Naturalistic experience with the use of divalproex sodium on an in-patient unit for adolescent psychiatric patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of sodium valproate in three patients with organic brain syndromes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of rapid cycling bipolar disorder with combination therapy of valproate and lithium

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and biological findings in a case with 48-hour bipolar ultrarapid cycling before and during valproate treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Valproate-associated pancreatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Carnitine deficiency: a possible mechanism for valproate hepatotoxicity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sodium valproate in the treatment of resistant epilepsy.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Valproate and curly hair

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Teratogen update: valproic acid

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

A reevaluation of risk of in utero exposure to lithium

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of lithium, carbamazepine, and valproic acid in a state-operated psychiatric hospital.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

The ability of lithium and other mood stabilizers to decrease suicide risk and prevent relapse

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2003.00031.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1399-5618.2003.00031.X

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35142736&oldid=1571212091"